Wide Open Agriculture has extended Univar Solutions China’s exclusive distribution rights for its lupin protein products through 2028, preserving a route into the mainland Chinese market. But the agreement is not a purchase order: revenue depends first on WOA restoring commercial supply through contract manufacturing.
- Exclusive mainland China distribution extended to 31 December 2028
- 50-tonne minimum purchase starts only after commercial supply is available
- WOA has not committed to a supply commencement date
- No immediate revenue or financial impact from the extension
- Four prospective contract manufacturing partners remain under evaluation
China Distribution Rights Extended to 2028
Wide Open Agriculture Ltd (ASX:WOA) has bought more time for its China commercialisation plan, extending Univar Solutions China’s exclusive right to market and distribute WOA’s lupin protein products in mainland China until 31 December 2028. Univar has completed customer trials and confirmed its commercial rollout strategy, according to WOA.
The extension preserves a distribution relationship with a sizeable ingredient channel, but it does not yet represent a sale. WOA said the agreement has no immediate financial impact, with no revenue due until commercial supply is restored and pricing is agreed between the parties.
50-Tonne Threshold Waits on Supply
Univar’s exclusivity remains conditional on a minimum purchase of 50 tonnes over a 12-month period. Crucially, that clock will not start until WOA confirms in writing that commercial quantities are available for supply. The agreement also does not require WOA to begin supplying by a specified date.
That makes manufacturing the operative milestone. WOA is transitioning away from its German facility, which has been wound down, and is seeking a contract manufacturing partner to restore supply. The shift follows the company’s capital-light manufacturing pivot in which it moved away from owning production infrastructure, while four prospective partners remain under evaluation.
Contract Manufacturing Remains the Commercial Hurdle
WOA said it is progressing framework agreements with four prospective contract manufacturers, with the objective of selecting a preferred long-term partner. The company’s earlier four-partner manufacturing shortlist was described as a feasibility exercise rather than secured production, and today’s announcement leaves the central dependency unchanged: supply must be restored before the Univar arrangement can generate revenue.
Univar’s marketing obligations continue during the extended term, including customer engagement, market development and product application trials, subject to reasonable access to product samples. If Univar materially fails to meet those commitments, WOA can convert the exclusive distribution right to non-exclusive after notice and an opportunity to remedy.
The Next Test Is a Purchase Order
WOA chief executive Craig Swan said the company’s priority is completing the contract manufacturing partner selection and restoring supply. Until that happens, the China agreement is best viewed as a preserved commercial option rather than booked demand. The more decisive announcement would be WOA’s confirmation that commercial quantities are available, followed by evidence that Univar’s 50-tonne commitment has translated into actual orders.
Bottom Line?
The extension protects WOA’s China route to market, but the investment case still turns on a manufacturing partner, restored supply and a first purchase order.
Questions in the middle?
- When will WOA select a preferred contract manufacturing partner and confirm commercial production?
- Will Univar’s customer trials convert into orders once supply becomes available?
- What pricing and gross economics can WOA secure when the 50-tonne purchase period begins?